MEDICINAL CANNABIS

CPH Seal Swiss Pharma Deal: Setting the Cornerstone for Global Commercialisation of cannaQIX

Next Investors Archived Dec 04, 2017

It has been a major month for Creso Pharma (ASX:CPH) as it continues to make potentially market moving announcements.

Budding ASX Junior Pens Transformative Medical Cannabis Deals: Now Generating Revenue

Next Investors Archived Nov 23, 2017

MGC Pharmaceuticals (ASX:MXC) was the second company to originally emerge in the ASX cannabis corridor, and with a whip-smart team that’s put in serious hours in the industry-leading Israeli medicinal marijuana scene, this ASX junior is rapidly coming into its own.

CPH signs deal to import and distribute its first human cannabinoid product into Australia

Finfeed Archived Nov 22, 2017

Creso Pharma Limited (ASX:CPH) today announced it had secured an important deal with its Australian distribution partner, Health House International, for the import and distribution of its first cannabinoid-based human health product.

Chapmans completes strategic investment in medical cannabis group, MJ Life Sciences

Finfeed Archived Sep 25, 2017

Diversified investment group, Chapmans Limited (ASX:CHP), has announced the company’s successful completion of its strategic investment in MJ Life Sciences (MJLS).

Chapmans to take strategic stake in medicinal cannabis group, MJ Life Sciences

Finfeed Archived Aug 30, 2017

Diversified investment group, Chapmans (ASX: CHP) announced on Tuesday that it had entered into a binding Heads of Agreement (HOA) with MJ Life Sciences (MJLS) with a view to making a strategic investment of $500,000 in MJLS, an Australian special-purpose company established with the aim of becoming a leading global medicinal cannabis holding and investment company.

CPH to Launch Innovative Hemp-based Animal Health Products with Virbac in Switzerland

Catalyst Hunter Archived Aug 06, 2017

CPH is a leading player in medicinal cannabis and cannabidiol (CBD) innovation, and develops cannabis and hemp-derived therapeutic-grade CBD nutraceuticals and medicinal cannabis products with wide patient and consumer reach for both human and animal health.

Creso gains exposure to world’s largest legal medicinal cannabis market

Finfeed Archived Jul 28, 2017

Creso Pharma Limited (ASX: CPH) has expanded into the Canadian market with the proposed acquisition of emerging Nova Scotia-based medicinal cannabis producer, Mernova Medicinal Inc (Mernova) for a total of C$10.1 million (A$10.2 million) in cash and equity.

CPH to Acquire Canadian Cannabis Grower and Strengthen Position in Multi-Billion Dollar Market

Next Investors Archived Jul 27, 2017

Creso Pharma (ASX:CPH) is now in the box seat to acquire 100% of Canadian-based Mernova Medicinal Inc., an acquisition that would position CPH as a Canadian producer of legal cannabis.

Chapmans investment in AZ Pharmaceuticals Inc facilitates entry into medicinal cannabis market

Finfeed Archived Jun 26, 2017

Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc., the owner of the Aunt Zelda’s medicinal cannabis business, to invest US$2 million in Aunt Zelda’s.

Is a Pending Medical Cannabis Deal about to Light up this ASX Stock?

Next Investors Archived Jun 16, 2017

Chapmans Ltd (ASX: CHP) is not the typical stock readers are accustomed to seeing here at The Next Small Cap. In fact, after scratching our collective temples, we couldn’t find any previous instances of us delving into a Listed Investment company (LIC).

CPH Signs Exclusive Cannapharm deal: On Track for 2017 Product Release

Next Investors Archived Jun 14, 2017

News of $100 million IPOs, alongside an avalanche of parallel legislative changes around the world, builds a strong case for the burgeoning medicinal marijuana industry. With so many medicinal cannabis stocks fighting for market share and threatening to steal the limelight, a company such as Creso Pharma Ltd (ASX: CPH) needs to do all it can to stay current and competitive.

Creso first to obtain export rights for high quality medicinal cannabis from Switzerland

Finfeed Archived Jun 01, 2017

Creso Pharma Limited (ASX:CPH) has signed a binding Letter of Intent (LOI) with Cannapharm AG to provide patients in Asia Pacific and Latin America (LATAM) access to top quality medicinal cannabis products from Switzerland.

CPH announces new deal with LeafCann to expand Australian offering

Finfeed Archived May 11, 2017

Creso Pharma Limited (ASX:CPH) has signed a strategic agreement with pre-eminent Australian medicinal cannabis producer LeafCann Group Pty Ltd (LeafCann).

Creso agreement with Health House sees first shipment of medical cannabis into Australia

Finfeed Archived May 02, 2017

Shares in Creso Pharma (ASX:CPH) could receive significant support after the company announced that it had formalized an agreement with its partner in Australia, Health House International Pty Ltd (Health House), following Health House’s successful import of the first medicinal cannabis products into Australia. It should be noted that share trading patterns should not be

CPH Deliver Australia’s First Medicinal Cannabis Shipment Under New Legislation

Next Investors Archived May 02, 2017

Creso Pharma (ASX: CPH) has made a shipment of medicinal cannabis into Australia – the first import into the country under new government legislation. Under an agreement between CPH and its Australian partner, Health House International Pty Ltd, the pair will distribute a range of cannabis oil products across Australian pharmacies, in compliance with Federal and State legislation.

Medicinal Cannabis